Chronic obstructive pulmonary disease (COPD); Anti-inflammatory nutritional supplementation therapy; Whey peptide; Pulmonary rehabilitation Summary Background: One of the major pathophysiologies in advanced chronic obstructive pulmonary disease (COPD) has been attributed to systemic inflammation. Meta-analysis of the 2005 Cochrane Database concluded the effect of nutritional supplementation alone on stable COPD was insufficient to promote body weight gain or exercise capacity. The aim of this study was to investigate the effectiveness of nutritional supplementation therapy using a nutritional supplement containing whey peptide with low-intensity exercise therapy in stable elderly patients with COPD. Method: In stable elderly COPD patients with %IBW and %FEV 1 of less than 110 and 80%, respectively, anti-inflammatory nutritional supplementation therapy was added to low-intensity exercise therapy. Thirty-six COPD patients were divided into those with and those without the ingestion of an anti-inflammatory nutritional supplement containing whey peptide, which exhibited an anti-inflammatory effect. These two groups were designated as the nutritional support and the control groups, respectively. The body composition, skeletal muscle strength, exercise tolerance, health-related QOL (HRQOL), and inflammatory cytokines were evaluated Abbreviations: %IBW, %ideal body weight; FM, fat mass; %AC, %arm circumference; PImax, maximum inspiratory mouth pressure; PEmax, maximum expiratory mouth pressure; 6MWD, 6-minute walking distance; WBI, weight bearing index; CRQ, chronic respiratory disease questionnaire.
Introduction
Advanced chronic obstructive pulmonary disease (COPD) is understood as a systemic inflammation mediated by cigarette smoking and air pollution, and subsequently induced inflammatory cytokines, such as tumor necrosis factor (TNF)-a, interleukin (IL)-6, and IL-8.
1,2 The involvement of these inflammatory cytokines and endocrine hormones has been shown to be related to the pathology of the reduction in exercise tolerance represented by skeletal myopathy and health-related QOL (HRQOL) in COPD patients. 3 According to the global initiative for chronic obstructive lung disease (GOLD), 4 both body mass index (BMI) and lean body mass (LBM) or fat-free mass (FFM) were reduced in about 25% of moderate-severe COPD cases. Malnutrition in COPD is considered to aggravate the pathology and promote complication by lung infection, the cause of acute deterioration, 5 for which the importance of nutritional therapy has recently been suggested.
Evidence for its efficacy even in patients without severe nutrient deficiency has been obtained, suggesting the necessity of nutritional supplementation therapy as a part of pulmonary rehabilitation (PR). 1, 2 Meta-analysis of the 2005 Cochrane Database 6 concluded that the effect of nutritional supplementation alone on stable COPD was insufficient to promote body weight gain or exercise capacity. However, it has been reported that combination therapy with nutritional supplementation and exercise training was effective in COPD. 7, 8 Thus, we used a new antinutritional supplement with whey peptide combined with low-intensity exercise therapy in stable elderly COPD patients whose body weight was less than 110% of the reference body weight (%ideal body weight: %IBW) and the %forced expiratory volume in 1 s (%FEV 1 ) was less than 80%, and investigated the effects on body composition, skeletal muscle strength, exercise tolerance, HRQOL, and inflammatory cytokines.
Subjects and methods (Table 1 , Fig. 1 
)
Thirty-six stable elderly COPD patients with %IBW <110% and %FEV 1 <80% who underwent low-intensity exercise therapy following the pulmonary rehabilitation (PR) program, and who met the diagnostic criteria of the COPD guidelines established by the American Thoracic Society (ATS), 9 were enrolled in the study between June 2009 and May 2010. Forced expiratory volume in 1 s (FEV1) had to be less than 70% of the reference value, and the increase in FEV1 after inhalation of a b2-agonist had to be less than 10% of the reference value.
There were 34 male and 2 female patients ( Table 1 ). The mean age was 77.2 AE 5.3 years; %IBW, 91.0 AE 11.4%; forced vital capacity (FVC), 2.7 AE 0.8 L; %forced expiratory volume in 1 s (%FEV 1 ), 44.5 AE 16.9%; maximum inspiratory mouth pressure (PImax), 53.8 AE 22.9 cmH 2 O; and 6-min walking distance (6MWD), 330 AE 200 m. The patients were randomly allocated employing the envelope method to a nutrition group (active nutritional supplementation therapy with 200 kcal/pack of nutritional supplement twice a day in addition to normal meals and dietary instruction) and a control group (normal meals alone with dietary instruction), and the parameters were evaluated before and 3 months after nutritional support with exercise therapy (Fig. 1) . The randomization was done with a double blind manner. The daily intake of the nutritional supplement was confirmed in a diary. Patients with a current cigarette smoking habit and complication of unstable heart disease, those for whom the medication was changed during the study period, those with severe disorders interfering with exercise including mental diseases and difficulty in oral ingestion of the nutritional supplement, and those in whom the condition was acutely aggravated after study initiation were excluded.
This study was reviewed and approved by the Ethics Committee of our hospital and Akita University School of Medicine, and carried out in conformity with the Declaration of Helsinki. 10 The objective and content of the study were orally explained to the participants in addition to using documents. Written consent was obtained after the subjects were informed that they could decide whether or not to participate based on their own free will and that their privacy would be sufficiently considered.
Assessments (Table 2)
The resting energy expenditure (REE) was measured using a portable simple calorimeter, Metavine (VINE Co., Tokyo, Japan). 11 The system was calibrated daily before the start of the experiment. The evaluations were performed at 9:00e10:00 in the morning fasting state in order to perform biochemical tests and REE measurement on fasting. REE was measured when subjects were comfortably lying on a bed in the supine position. REE was calculated from oxygen consumption and carbon dioxide production with an abbreviated Weir formula. 12 Of the physical measurements, %TSF, %AC, and %AMC were calculated by dividing the measured values by the means of JARD2001. 13 Before and during the last week of nutritional therapy, patients were asked to register their food intakes over 3 consecutive days in order to assess dietary intake. The obtained information was coded for computer nutrient analysis. The nutrient database was derived from the Standard Tables of Food Composition (The Science and Technology Agency of Japan, 1982). Dietary intake was calculated by taking the average intake over 3 days. The use of dietary records provides a good representation of the actual food consumption because food intake is averaged over 3 consecutive days, so the effects of day-to-day variations are largely removed. 11 Total protein, carbohydrate, and fat intakes are presented as percentages of total energy intake. The total protein intake is also expressed as grams per kilogram of bodyweight every 24 h.
For biochemical testing, albumin (Alb), hemoglobin (Hb), and transferrin (Tf) were measured as nutrition indices, TNF-a, IL-6, IL-8, and high-sensitivity C-reactive protein (hsCRP) as inflammatory markers. The level of hsCRP was assessed by latex turbidimetric immunoassay (Nittobo Medical; Tokyo, Japan), and the analytical sensitivity of this hsCRP assay is 0.1 mg/L. Serum TNF-a, IL-6, and IL-8 were measured using commercially available enzyme-linked immunosorbent assay kits (SRL, Inc., Tokyo, Japan).
The mouth pressure was measured as respiratory muscle strength using VITALOPOWER KH-101 (CHEST MI Inc., Tokyo, Japan) following the method reported by Black and Hyatt. 14 For the weight-bearing index (WBI), the maximum isometric extension and contraction of the quadriceps femoris muscle Evaluation at 3months after study initiation Abbreviation; COPD , chronic obstructive pulmonary disease , %IBW , %ideal body weight , %FEV1 %forced expiratory volume in one second Figure 1 Study protocol.
were measured at 0 deg/s 80 flexion using HYDRO MUSCULATOR GT-160 (OG Giken Co., Ltd., Tokyo, Japan).
To measure exercise performance, patients performed a corridor walk for 6 min according to the ATS guidelines. 15 The distance walked in 6 min (6MWD) and the dyspnea scale were used in the analysis. Patients were not encouraged during the walk. 16 The disease-specific HRQOL was measured using the Japanese version of the Chronic Respiratory Disease Questionnaire (CRQ). 17 The questionnaire scores four domains: dyspnea, fatigue, emotion, and mastery. It contains 123 items, of which 62 deal primarily with physical function and 61 with emotional function. 17 The results are presented as mean scores per question in each dimension. The threshold for clinically significant change for each dimension has been previously identified as 0.5.
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Nutritional supplement (Table 3) MEINä (Meiji Dairies Corporation, Tokyo, Japan) was used as the nutritional supplement in this study. One pack of MEINä contains 200 kcal/200 ml, and the energy balance per pack is as follows: protein, 20%; lipids, 25%; sugars, 53.2%; food fibers, 1.8%; and Fisher ratio, 3.7 (Table 3 ). The characteristics of MEINä are that whey peptide with an anti-inflammatory and antioxidant effect, nÀ3 fatty acids (nÀ6:nÀ3 Z 2:1), and antioxidant vitamin A, C and E are enriched.
19e21 Patients were directed to take two packs of MEINä, and the daily intake of the nutritional supplement was confirmed in a diary.
Exercise program
A multidisciplinary home-based low-intensity PR program 16 was used in the present study (Fig. 2) . Briefly, breathing retraining consisted of pursed-lip breathing, diaphragmatic breathing, and slow deep breathing, in both the supine and sitting positions. Exercise training included upper and lower limb exercises, respiratory muscle stretching calisthenics, 8, 22 level walking for least 15 min, and inspiratory and expiratory muscle exercises using Thresholdä (HealthScan Products Inc., Cedar Grove, NJ) set at a training intensity of 20e30% of the maximal inspiratory (PImax) and expiratory (PEmax) muscle forces. Patients also underwent a monthly 45-min education program including lectures and discussions on respiratory disease, control of dyspnea, medication and equipment use, nutrition, stress management, relaxation techniques, home exercises, and the benefits of PR. Patients were strongly instructed to practice this program daily at home and were supervised by a physiotherapist every 2 weeks in our hospital. 8, 22 A nurse periodically visited each patient at 
Respiratory muscle strength(PImax and PEmax) Weight-bearing index(WBI) Six-minute walking distance(6MWD) Borg scale before and after 6MWD HRQOL(CRQ)
Abbreviation: TNF-a, tumor necrosis factor-a; IL, interleukin; hsCRP, high-sensitivity C-reactive protein; PImax, maximum inspiratory mouth pressure; PEmax, maximum expiratory mouth pressure; and CRQ, chronic respiratory disease questionnaire.
home, supervising and providing information regarding the role of the PR program. Relaxation and stair-climbing exercises were also carried out under the supervision of the physiotherapist when the patients visited the hospital. The overall training intensity was set at 40e50% of the maximum oxygen consumption. 8 
Statistics
All parameters (baseline values and change after the nutritional intervention) were, firstly, checked for normality of distribution. When variables were normally distributed and equal variances could be assumed, Student's paired t test was applied to compare the difference between the baseline value and that at 3 months after nutritional intervention. Student's unpaired t test was applied to compare the difference between the nutrition and control groups. In both tests, the difference was regarded as significant when the significance level was less than 5%.
Results Table 1 lists the baseline parameters of the study group. As expected, lung function was severely impaired with the reference values. No baseline differences between the nutrition with exercise group and the control group were seen with regards to age, body weight, %IBW, REE, FVC, FEV 1 , 6MWD, and CRQ (Table 1) . The daily intake of MEINä was 1.5 AE 0.5 packs in the nutrition group. Body weight, %IBW, FFM, and %AMC increased significantly after 12 weeks of anti-inflammatory nutritional supplementation with exercise therapy (Table 4 ). The dietary energy intake and protein intake increased significantly in the nutrition with low-intensity exercise group compared with those in the control group (Table 4) . In the nutrition with low-intensity exercise group, hsCRP, IL-6, IL-8, and TNF-a decreased significantly after intervention compared with those in the control group (Table 4) . MRC, PImax, 6MWD, quadriceps muscle force, WBI, and 6MWD increased significantly from baseline through week 12 in the nutrition with low-intensity exercise group compared with those in the control group (Table 4 , Fig. 3 ). Health status, as assessed by the chronic respiratory questionnaire, improved significantly in the total scores and the domain of emotional function after intervention in the nutrition with low-intensity exercise group compared with that in the control group (Table 4, Fig. 3 ).
Discussion
We report herein the results of a pilot study of a combination of anti-inflammatory nutritional support using supplement contained whey peptide and home-based low-intensity exercise in elderly patients with COPD. The combination of anti-inflammatory nutritional supplementation with whey peptide and low-intensity exercise training was successful in increasing weight and energy Abbreviation: %IBW, ideal body weight; FM, fat mass; FFM, fat free mass; FMI, fat mass index; FFMI, fat free mass index; REE, resting energy expenditure; %AC, % arm circumference; Alb, albumin; hsCRP, high sensitivity C reactive protein; IL, interleukin; TNF, tumor necrosis factor; MRC, medical research council; PImax, maximum inspiratory mouth pressure; PEmax, maximum expiratory mouth pressure; 6MWD, six-minute walking distance; WBI, weight bearing index; and CRQ, chronic respiratory disease questionnaire.
intake as well as exercise capacity and HRQOL in our patients. Moreover, major inflammatory cytokines decreased significantly after anti-inflammatory nutritional supplementation with low-intensity exercise training. This study suggests that there is a potential role for the combination of anti-inflammatory nutritional support with whey peptide and low-intensity exercise in the management of patients with COPD. High inflammatory cytokine levels such as IL-6, IL-8, and TNF-a have been shown to be characteristics of advanced muscle loss and associated with weight loss. 23, 24 The serum TNF-a level was high in COPD patients, 25 TNF-a production by peripheral monocytes was enhanced in patients with weight loss, 26 and the elevated blood inflammatory cytokine level, such as IL-6 and IL-8, has also been pointed out to be one of the causes of metabolic enhancement in COPD patients with malnutrition.
1,2 Moreover, TNF-a was reported to be involved in the induction of skeletal muscle cell apoptosis. 3 The reduction of FFM lowers exercise tolerance and serves as a poor prognostic factor and the association of a high cytokine level with low muscle mass and muscle strength has been reported. 27 COPD is characterized by a specific pattern of inflammation involving neutrophils, macrophages, and lymphocytes. 28 These cells release inflammatory mediators such as IL-6, IL-8, and TNF-a and interact with structural cells in both the lung and airway. 29 Our data demonstrate significant increases in the levels of IL-6 and IL-8 in patients with COPD, and these data are in line with previous studies. 1, 2, 30, 31 We have shown that the levels of elevated inflammatory cytokines decreased significantly after intervention with an anti-inflammatory nutrition combined with the low-intensity exercise in this study. We used an antiinflammatory nutritional supplement in which whey peptides are enriched in this study. Whey protein, a protein complex derived from milk, includes a-lactalbumin, lactoferrin, b-lactoglobulin, glycomacropeptide, and immunoglobulins, and has the ability to act as an antioxidant, antitumor, and antiviral agent in vitro and in vivo. a-Lactalbumin 32,33 and lactoferrin, 34, 35 components of whey peptide, have recently been shown to inhibit production of the inflammatory cytokines such as TNF-a and IL-6 in rat or human monocytes. Whey protein supplementation has also been shown to have salient hepatoprotective effects on D-galactosamine-induced hepatitis in rats by inhibition of IL-b and IL-6. 36 Thus, taking these findings together, it has been suggested that the positive result in increasing the body weight and improving exercise tolerance and HRQOL in this study were attributable mainly to the anti-inflammatory effect of whey peptide in nutritional support. Our data are in line with the recent nutritional study 7 in which pressurized whey was used. However, inflammatory cytokines and oxidant/antioxidant markers had not been decreased significantly in the previous study. There were two possible explanations of the difference between our study and the previous study: (1) different components of whey peptide were employed between the two studies, and (2) low-intensity exercise therapy was used in our study while high-intensity exercise in the previous study. First as whey protein in our study includes a-lactalbumin, lactoferrin, b-lactoglobulin, glycomacropeptide, and immunoglobulins which might inhibit production of inflammatory cytokines. Second the intensity of the exercise therapy which was used in our study was low, while the intensity of exercise therapy in the previous study was so high that oxidative stress might have been induced. In order to resolve these questions, it is necessary to verify which component of whey is essential to inhibit inflammatory cytokines in nutritional support. Thus, a multicenter clinical study involving an increased number of patients is warranted to verify the effectiveness of whey peptide in anti-inflammatory nutritional supplementation therapy in the near future.
Many researchers consider that nutritional supplementation alone is ineffective for body weight gain and functions in COPD, 1, 2, 6 showing that muscle strength training followed by planned nutritional supplementation is the best possible method to increase muscular protein content. Human skeletal muscle has been shown to be one of the main sources of IL-6, and muscle-derived IL-6 stimulates CRP production in the liver. 37, 38 It has recently been shown that exercise-induced muscle-derived IL-6 is reduced after low-intensity endurance training. 39 Taking these findings together, our data showing inhibition of IL-6 and CRP, after 3-month intervention with an anti-inflammatory nutritional support and low-intensity exercise training, suggest that inhibition might have occurred, at least in part, in the skeletal muscle, not in the lung or the airway.
It has been shown that a habitual exercise program prevented an increase in oxidative stress 40 and muscle strength training reduced the cytokine level in elderly persons. 41 The recent average life span in men is 80 years old in men and 86 years old in women in Japan. Accordingly, the age of COPD patients is higher in Japan. Exercise therapy to maintain or increase the muscle mass should be considered to reduce a high inflammatory cytokine level in COPD patients, who are mostly elderly. To maintain or increase the muscle mass, in addition to active muscle strength training, nutritional supplementation by the ingestion of protein and carbohydrates is indicated. 42, 43 The combination of muscle strength training and nutritional supplementation increases the net acquired protein balance (skeletal muscle protein synthesis-skeletal muscle proteolysis), 44 which may increase the body weight accompanied by an increase in FFM and improve physical function in COPD patients. 45 In elderly COPD patients who are likely to lose weight owing to an increase in the energy expenditure and a decrease in the energy intake over the disease course, skeletal muscle dysfunction may reduce exercise tolerance and influence the HRQOL. If the effect of pulmonary rehabilitation is partially due to body weight gain induced by nutritional therapy, and recovery of the skeletal muscle function and exercise tolerance is promoted by exercise therapy, the combination of antiinflammatory nutritional supplementation and lowintensity exercise may be an effective treatment.
On the basis of the above findings, the combination of anti-inflammatory nutritional supplementation therapy using nutritional support containing whey peptide with an anti-inflammatory effect and low-intensity exercise may not only promote body weight gain by nutritional supplementation but also improve exercise tolerance and HRQOL by inhibiting systemic inflammation in stable COPD patients with %IBW <110% and %FEV 1 <80%. The sample size and the time period used in our study were insufficient to reach a definitive conclusion. We believe that a study on a larger scale and for a longer period of time should be conducted to assess the effectiveness of anti-inflammatory nutritional supplementation with whey peptide and low-intensity exercise during rehabilitation in patients with COPD.
Conclusion
Although no definitive evidence for the usefulness of nutritional supplementation therapy has been established, our clinical study results suggested that additional antiinflammatory nutritional supplementation therapy with whey peptide for stable elderly COPD patients (%IBW <110%, %FEV 1 <80%) under low-intensity exercise therapy may improve exercise tolerance and the HRQOL by inhibiting systemic inflammation as an additive effect. The effect of the combination of anti-inflammatory nutritional supplementation and low-intensity exercise therapies may be worth closely investigating through a clinical study involving a large number of cases.
